## Abstract An attempt was made to identify factors influencing the cumulative probability of an increased alanine aminotransferase (ALT) level and hepatocarcinogenesis in hepatitis C patients with a normal ALT level initially. A total of 398 consecutive patients with a normal ALT level initially f
Long term follow up of thalassemic patients with hepatitis C and normal aminotransferases treated with interferon-alpha
β Scribed by H. Berdoussi; A. Manolaki; S. Kostaridou; V. Ladis; L. Nakopoulou; C. Kattamis
- Book ID
- 118565263
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 214 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986
We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only